Skip to main content
Log in

Time to relax GMO regulation in Europe

  • Review
  • Published:
Plant Cell, Tissue and Organ Culture Aims and scope Submit manuscript

Abstract

There is enough experience gained during 10 years of genetically modified (GM) crops application to seriously evaluate the ratio of risk to benefit and reduce the existing regulation in Europe. It does not evaluate benefit and the risk of the alternative situation when GM crops are not used. The precautionary principle is applied only to GM crops application, never to alternative solutions of, e.g., pest control. The Eurobarometer 2005 shows how propaganda inseminates public opinion with shameful nonsense. Voices asking for change of this politics come from the European Parliament, British ACRE, EuropaBio, even from Commission, scientists and other European sources, but also from Africa and other developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • ACRE (2007) Wider issues raised by the farm-scale evaluations of herbicide tolerant GM crops, Report of the ACRE Sub-Group revised after public consultation, 3 May 2007

  • Cantley M (1995) The regulation of modern biotechnology: a historical and European perspective. In: Rehm H-J, Reed G (eds) Biotechnology. Weinheim, Berlin

    Google Scholar 

  • Cantley M (2007) Innovations Report Feb. 26, 2007

  • Council of Europe (1990a) Council directive 219/EEC on the contained use of genetically modified microorganisms

  • Council of Europe (1990b) Council directive 220/EEC on the deliberate release into the environment of the genetically modified organisms

  • Dimas S (2006) Speech at the conference on GMO co-existence, Vienna, April 5 2006

  • DG III (2000) Economic impacts of genetically modified crops on agri-food sector. Working document Directorate-General for Agriculture, Brussels 2000

  • European Commission (2000) Communication from the commission on the precautionary principle, COM (2000).1, Brussels 02.02.2000

  • European Commission (2003) Lack of information and public scepticism on agricultural biotechnology contribute to biotech companies leaving Europe. IP/03/387, Brussels, 14 March 2003

  • European Parliament (2006) On biotechnology: prospects and challenges for agriculture in Europe. Draft Report by Committee on Agriculture and Rural Development, Provisional 2006/2059 (INI)

  • European Parliament and Council (2001) Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC

  • European Parliament and Council (2003a) Regulation of the European Parliament and of the Council on genetically modified food and feed 1829/2003

  • European Parliament and Council (2003b) Regulation of the European Parliament and of the Council concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms and amending Directive 2001/18/EC 1830/2003

  • Food Standard Agency (2003) Electronic source: contaminated maize meal withdrawn from sale, http://www.food.gov.uk/news/newsarchive/2003/sep/maize and http://www.food.gov.uk/news/newsarchive/2003/sep/moremaize and http://www.food.gov.uk/multimedia/pdfs/maizemeal10.pdf

  • Garthoff B (2007) The green biotechnology Manifesto, EuropaBio Press release, Lyon, France 13 March 2007. http://www.europabio.org/ne_Greenmanifesto130307.htm

  • Gaskell G, Allansdottir A, Allum N et al (2006) Europeans and biotechnology in 2005: patterns and trends. Eurobarometer 64.3—A report to the European Commission’s Directorate-General for Research

  • Gómez-Barbero M, Rodríguez-Cerezo E (2006) Economic impact of dominant GM crops worldwide: a review. Institute for Prospective Technological Studies, JRC, EUR 22547

  • James C (2006) Global status of commercialized biotech/GM crops, ISAAA Brief 35

  • Kalaitzandonakes N (2007) Compliance costs for regulatory approval of new biotech crops. Nature Biotechnol 25:509–511

    Article  CAS  Google Scholar 

  • Mandelson P (2007) Speech at the European biotechnology info day bavarian representation, Brussels, 14 June 2007

  • May R (2003) From the President Lord May of Oxford OM AC Kt PRS, 10 November 2003, Policy no: 27/03

  • van Montagu M (2007) Innovations report, Feb. 26, 2007

  • Morris SH (2007) Parallel biopolitical universes. Nature Biotechnol 25:33

    Article  CAS  Google Scholar 

  • Nature Biotechnology (2006) GM products will continue to be marginalized in Europe as long as industry remains silent. Editorial-24, p 1178; Oct. 2006

  • Sommer R (2007) Against all our interests. Parliament Mag 53, January 29, 2007

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jaroslav Drobník.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drobník, J. Time to relax GMO regulation in Europe. Plant Cell Tiss Organ Cult 94, 235–238 (2008). https://doi.org/10.1007/s11240-007-9331-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11240-007-9331-3

Keywords

Navigation